CMP Pharma

CMP Pharma is a U.S.-based specialty pharmaceutical company focused on FDA-approved oral liquid and semi-solid formulations for patients who need alternatives to conventional solid oral dosage forms, particularly those with swallowing difficulties. The company develops, manufactures, and commercializes branded, generic, prescription, and non-prescription products for hospital, long-term care, and retail channels. Its marketed portfolio includes CaroSpir, Norliqva, Tadliq, Atorvaliq, SPS Suspension, Oracit, Isoniazid oral solution, and topical dermatology products such as Absorbase and Dermacloud. CMP Pharma emphasizes niche formulations that can replace crushing or compounding practices with approved liquid products and manufactures from its Farmville, North Carolina facility. The company appears to be privately held and backed by healthcare-focused investor Altaris Capital Partners.